Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Infectious diseases 5

Infectious Diseases

Pharma News Merck, AstraZeneca, and GSK

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Merck’s Sotatercept Trial Result; PARP Rivals Closing in on AstraZeneca and Merck’s Lynparza; FDA Clears GSK’s Boostrix for Pertussis; Fast Track Designation to Nanoscope Therapeutics’s MCO-010; FDA Awards Fast Track Designation to Eftilagimod Alpha Plus Pembrolizumab; Solid Biosciences to Acquire AavantiBio

Merck’s Sotatercept Clears Phase III Trial Merck’s USD 11.5 billion acquisition of Acceleron last year was based on the promise of pulmonary arterial hypertension (PAH) candidate sotatercept, which has recently met the mark in a much-anticipated phase III trial. The STELLAR trial found that adding the activin receptor type IIA-Fc (ActRIIA-Fc) fusion protein to stable background therapy resulted in a significant increase in exercise capacity measured using the six-minute walking test in PAH patients, meeting the trial’s primary objectives. Furthermore, the drug met 8 of 9 secondary endpoints in the study, except for one that looked at the emotional and cognitive ...

Explore More...

medtech-news-for-boston-scientific-bd-roche-linus-helioliver

Boston Scientific’s MODULAR CRM System; Restore Medical’s ContraBand clinical trial result; BD acquires Venclose; Roche differentiates mutations in Omicron; Linus’s StrandDx-ASD; HelioLiver launches liquid biopsy test

medtech-news-for-lensgen-ge-nevro-hyperfine-immunexpress

LensGen’s Juvene Intraocular Lens; Nevro announces clinical data publications; FDA Clearance to Immunexpress’s SeptiCyte; GE unveils AI and Digital Technologies; Canon launches PIQE DLR and SilverBeam; Hyperfine’s Swoop gets FDA clearance

pharma-news-for-ge-optellum-therapixel-ocugen-blueprint

GE Healthcare-Optellum’s collaboration; Ocugen’s Covid-19 vaccine trial; Blueprint to acquire Lengo Therapeutics; Therapixel’s Mammoscreen

pharma-news-for-bluebird-bio-fda-twist-bioscience-sosei-heptares

Bluebird bio may get gene therapy approved in the US; Neurocrine pens $2.6B pact with Sosei Heptares; FDA opens clearances for hepatitis C diagnostics; Twist nabs antibody discovery biotech Abveris for $190M

HIV-Therapeutics-Market-drugs-companies-epidemiology-population

Top Drugs To Watch in HIV (2025)

medtech-news-and-updates-for-abbott-ivantis-medtronic-alung-appliedvr-orthalign

Abbott’s Pacemaker System; Ivantis’s Hydrus Microstent; Medtronic’s PillCam Small Bowel 3; ALung Technologies’s Hemolung; AppliedVR’s EaseVRx; J&J to split into two companies; OrthAlign’s Lantern® launch; LumiThera’s Light-based Theranostic

covid-19-and-the-social-determinants-of-health

Social Determinants of Health and their Impact on COVID-19

HIV-1-treatment-market

Changing Dynamics of HIV-1 Treatment Market

medtech-news-for-naviswiss-allosource-spinafx-starfish-smith-nephew

FDA 510k clearance to Naviswiss’s Naviplan; FDA approved to TYRVAYA; Centinel Spine’s STALIF Integrated Interbody System; Smith+Nephew’s IODOSORB; AlloSource’s AlloMend Extra-Large ADM; SpinaFX and StarFish’s strategic commercialisation contract

Probiotics Market

Analyzing the Emerging Demand for the Probiotics

pharma-biotech-news-updates-for-biogen-smartlabs-synlogic-partner-therapeutics

Biogen’s AMD Biosimilar Gets Approval; SmartLabs Series B Funding; BARDA, Partner Therapeutics in Sepsis Space; Synlogic to Explore Sepsis Market Domain

onychomycosis-market-CAGR-size-share-trends-growth-population-epidemiology-therapy-therapeutics-treatment

Onychomycosis Therapy Market Set to Balloon Up as Emerging Novel Therapies Continue to Adorn the Space

recent-pharma-news-and-updates-for-Pfizer-Forte-Biosciences- Bone-Therapeutics-Versanis-Bio-AC-Immune

Pfizer’s RSV Vaccine; Forte Biosciences’ Atopic Dermatitis Asset; Bone Therapeutics’ Osteoarthritis Programme; JandJ’s HIV Vaccine Trial; Versanis Bio $70 M Series A Financing; AC Immune’s Alzheimer’s Antibody Drug

venous-thromboembolism-market-size-share-trends-companies-cagr-growth-therapy-treatment-therapeutics

Venous Thromboembolism Market Growth Quadrant to Balloon Up

recent-pharma-news-updates-for-hebabiz-pfizer-astrazeneca-bms-masimo

AstraZeneca’s Ultomiris; HebaBiz’s Siroquine; Pfizer’s XELJANZ; Bristol Myers Squibb’s Opdivo; and Masimo’s PVi

Latest-pharma-biotech-news-updates-for-gsk-pfizer-biontech-biovac-seres-therapeutics

Commencement of AAIC; GSK’s Shingles Vaccine Expanded Approval; Pfizer/ BioNtech Agreement with Biovac; Another Failure in Ulcerative Colitis Trial

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly